PT Millennium Pharmacon International Tbk (SDPC) Stock Statistics & Valuation Metrics

PT Millennium Pharmacon International Tbk has a market cap or net worth of IDR 233.14B. The enterprise value is IDR 1.03T.

Market Cap

IDR 233.14B

Enterprise Value

IDR 1.03T

PT Millennium Pharmacon International Tbk has 1,274,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,274,000,000

Owned by Insiders

―

Owned by Institutions

―

PT Millennium Pharmacon International Tbk’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.

Return on Equity (ROE)

0.12

Return on Assets (ROA)

0.02

Return on Invested Capital (ROIC)

8.78%

Return on Capital Employed (ROCE)

0.32

Revenue Per Employee

3.43B

Profits Per Employee

32.14M

Employee Count

1,197

Asset Turnover

2.10

Inventory Turnover

6.19

The current PE Ratio of PT Millennium Pharmacon International Tbk is 5.65. PT Millennium Pharmacon International Tbk’s PEG ratio is 0.05.

PE Ratio

5.65

PS Ratio

0.05

PB Ratio

0.70

Price to FCF

-1.33

Price to Operating Cash Flow

-1.85

PEG Ratio

0.05

In the last 12 months, PT Millennium Pharmacon International Tbk had revenue of 4.11T and earned 38.47B in profits. Earnings per share was 30.20.

Revenue

4.11T

Gross Profit

338.96B

Operating Income

129.60B

Pretax Income

48.90B

Net Income

38.47B

EBITDA

153.00B

Earnings Per Share (EPS)

30.20

In the last 12 months, operating cash flow was -125.90B and capital expenditures -49.32B, giving a free cash flow of -175.21B billion.

Operating Cash Flow

-125.90B

Free Cash Flow

-175.21B

Free Cash Flow per Share

-137.53

PT Millennium Pharmacon International Tbk pays an annual dividend of ―, resulting in a dividend yield of 1.64%

Dividend Per Share

―

Dividend Yield

1.64%

Payout Ratio

N/A

Free Cash Flow Yield

-75.15%

Earnings Yield

17.71%

Beta

0.50

52-Week Price Change

32.61%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

33.13

Average Volume (3m)

644.60K

PT Millennium Pharmacon International Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 30, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

―

PT Millennium Pharmacon International Tbk as a current ratio of 1.10, with Debt / Equity ratio of 256.57%

Current Ratio

1.10

Quick Ratio

0.71

Debt to Market Cap

4.10

Net Debt to EBITDA

4.88

Interest Coverage Ratio

2.00

In the past 12 months, PT Millennium Pharmacon International Tbk has paid 10.43B in taxes.

Income Tax

10.43B

Effective Tax Rate

0.21

PT Millennium Pharmacon International Tbk EV to EBITDA ratio is 7.63, with an EV/FCF ratio of -6.55.

EV to Sales

0.27

EV to EBITDA

7.63

EV to Free Cash Flow

-6.55

EV to Operating Cash Flow

-9.11

PT Millennium Pharmacon International Tbk has IDR 33.78B in cash and marketable securities with IDR 947.74B in debt, giving a net cash position of -IDR 913.96B billion.

Cash & Marketable Securities

IDR 33.78B

Total Debt

IDR 947.74B

Net Cash

-IDR 913.96B

Net Cash Per Share

-IDR 717.40

Tangible Book Value Per Share

IDR 255.00

Gross margin is 8.59%, with operating margin of 3.14%, and net profit margin of 0.96%.

Gross Margin

8.59%

Operating Margin

3.14%

Pretax Margin

1.31%

Net Profit Margin

0.96%

EBITDA Margin

3.50%

EBIT Margin

2.98%

The average price target for PT Millennium Pharmacon International Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

9.85%

EPS Growth Forecast

188.27%